Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

[New influenza A (H1N1): advised indication and prescription of antiviral drugs].

van den Wijngaard CC, van Steenbergen JE, van der Sande MA, Koopmans MP.

Ned Tijdschr Geneeskd. 2009;153:A1053. Dutch.

PMID:
19857317
2.

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S.

Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.

3.

The use of antiviral agents for the management of severe influenza.

Smith JR, Ariano RE, Toovey S.

Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Review.

PMID:
19935416
4.

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.

Esposito S, Molteni CG, Colombo C, Daleno C, Daccò V, Lackenby A, Principi N.

J Clin Virol. 2010 May;48(1):62-5. doi: 10.1016/j.jcv.2010.02.019. Epub 2010 Mar 23.

PMID:
20335065
5.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
6.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Sep 11;58(35):969-72.

7.

[Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].

Aardema H, Tulleken JE, van den Biggelaar RJ, Wolters BA, de Jager CM, Boucher CA, Riezebos-Brilman A.

Ned Tijdschr Geneeskd. 2010;154:A1634. Dutch.

PMID:
20482913
8.

Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.

Wang SQ, Du QS, Huang RB, Zhang DW, Chou KC.

Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.

PMID:
19523442
9.

Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.

Sugaya N, Tamura D, Yamazaki M, Ichikawa M, Kawakami C, Kawaoka Y, Mitamura K.

Clin Infect Dis. 2008 Aug 1;47(3):339-45. doi: 10.1086/589748.

10.

[Naturally occurring oseltamivir resistance in influenza A].

Madsen L, Nielsen A, Lundgren J.

Ugeskr Laeger. 2010 Aug 9;172(32):2165-7. Danish.

PMID:
20696118
11.

Tamiflu: what dermatologists need to know.

Bergstrom KG.

J Drugs Dermatol. 2010 Jan;9(1):76-8.

PMID:
20120431
12.

Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Kawashima T, Hirotsu N, Kashiwagi S.

Clin Infect Dis. 2009 Apr 1;48(7):996-7. doi: 10.1086/597360. No abstract available.

13.

Treatment and prevention of influenza: Swedish recommendations.

Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(1):3-11. Review.

PMID:
12685876
14.

U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.

Borders-Hemphill V, Mosholder A.

Influenza Other Respir Viruses. 2012 Nov;6(6):e129-33. doi: 10.1111/j.1750-2659.2012.00384.x. Epub 2012 Jun 9.

15.

Five years of non-prescription oseltamivir: effects on resistance, immunization and stockpiling.

Gauld NJ, Jennings LC, Frampton C, Huang QS.

J Antimicrob Chemother. 2012 Dec;67(12):2949-56. doi: 10.1093/jac/dks337. Epub 2012 Sep 4.

16.

Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.

Speers DJ, Williams SH, Pinder M, Moody HR, Hurt AC, Smith DW.

Med J Aust. 2010 Feb 1;192(3):166-8.

PMID:
20121687
17.

Swine flu outbreak. What role for antiviral drugs?

Couzin-Frankel J.

Science. 2009 May 8;324(5928):705. doi: 10.1126/science.324_705. No abstract available.

PMID:
19423784
18.

Intravenous zanamivir in critically ill patients due to pandemic 2009 (H1N1) influenza A virus.

Wijaya L, Chua YY, Cui L, Chan K, Tan BH.

Singapore Med J. 2011 Jul;52(7):481-5.

19.

FDA notifications. EUA issued for treating novel 2009 H1N1 flu.

[No authors listed]

AIDS Alert. 2009 Jun;24(6):69-70. No abstract available.

PMID:
19544608
20.

Antivirals and influenza: frequency of resistance.

Monto AS.

Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S110-2. doi: 10.1097/INF.0b013e318168b739.

PMID:
18820569
Items per page

Supplemental Content

Write to the Help Desk